Pituitary adenylate cyclase‐activating polypeptide, helospectin, and vasoactive intestinal polypeptide in human corpus cavernosum

British Journal of Pharmacology

Volumn 116, Issue 4, 1995, Pages 2258-2266

  Hedlund, P ^a   Alm, P ^a   Ekstrom P ^a,b   Fahrenkrug, J ^a   Hannibal, J ^a   Hedlund, H ^a   Larsson, B ^a   Andersson, K E ^a  

^a UNIVERSITY OF COPENHAGEN   (Denmark)

^b LUND UNIVERSITY HOSPITAL   (Sweden)

Author keywords

cyclic AMP; immunohistochemistry, confocal microscopy, radioimmunoassay; Non adrenergic, non cholinergic; relaxation

Indexed keywords

CYCLIC AMP; CYCLIC GMP; CYCLIC NUCLEOTIDE; HELOSPECTIN; HYPOPHYSIS ADENYLATE CYCLASE ACTIVATING POLYPEPTIDE; NORADRENALIN; VASOACTIVE INTESTINAL POLYPEPTIDE;

ADULT; AGED; ARTICLE; CLINICAL ARTICLE; CONCENTRATION RESPONSE; CONTROLLED STUDY; CORPUS CAVERNOSUM; DIABETES MELLITUS; HUMAN; HUMAN TISSUE; HYPOPHYSIS; IMMUNOHISTOCHEMISTRY; MALE; MICROSCOPY; NERVE; PENIS ERECTION; PRIORITY JOURNAL; PROTEIN LOCALIZATION; RADIOIMMUNOASSAY; VASOCONSTRICTION;

ADULT; AGED; CYCLIC AMP; CYCLIC GMP; ELECTRIC STIMULATION; FLUORESCEIN-5-ISOTHIOCYANATE; HUMAN; IMMUNOHISTOCHEMISTRY; IN VITRO; MALE; MICROSCOPY, CONFOCAL; MIDDLE AGE; MUSCLE RELAXATION; NEUROPEPTIDES; NOREPINEPHRINE; PENILE ERECTION; PENIS; PEPTIDES; SUPPORT, NON-U.S. GOV'T; VASOACTIVE INTESTINAL PEPTIDE; VASOCONSTRICTOR AGENTS;

EID: 0028839512     PISSN: 00071188     EISSN: 14765381     Source Type: Journal    
DOI: 10.1111/j.1476-5381.1995.tb15062.x     Document Type: Article

References (57)

1. Neuropeptides of the vasoactive intestinal peptide/helodermin/pituitary adenylate cyclase activating peptide family elevate plasma cAMP in mice: comparison with a range of other regulatory peptides
2. Vascular effects of pituitary adenylate cyclase activating peptide: a comparison with vasoactive intestinal peptide
3. Helospectin‐like peptides in the gastrointestinal tract: immunocytochemical localization and immunochemical characterization
4. Is vasoactive intestinal polypeptide the principal transmitter involved in human penile erection?
5. Immunohistochemical localization of peripheral nitric oxide synthase‐containing nerves using antibodies raised against synthesized C‐ and N‐terminal fragments of a cloned enzyme from rat brain
6. The pharmacology of lower urinary tract smooth muscles and penile erectile tissues
7. Physiology of penile erection
8. Helodermin‐like peptides in noradrenaline cells of adrenal medulla
9. A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein‐dye binding
10. Nitric oxide: a physiologic mediator of penile erection
11. Immunohistochemical localization of nitric oxide synthase in the autonomic innervation of the human penis
12. Type I receptors for PACAP (a neuropeptide even more important than VIP?)
13. Effects of PACAP on morphologically identified myenteric neurons in guinea pig small bowel
14. Helospectin‐like immunoreactivity in the esophagus
15. Radioimmunoassay of vasoactive intestinal polypeptide (VIP) in plasma
16. Distribution of vasoactive intestinal polypeptide in the porcine central nervous system. J
17. Hypothalamic binding sites for pituitary adenylate cyclase activating polypeptide: characterization and molecular identification
18. Vascular effects of helodermin, helospectin 1 and helospectin 2: a comparison with vasoactive intestinal peptide (VIP)
19. Peptidergic innervation of the human male genital tract
20. The visualisation of cardiovascular innervation in the guinea pig using an antiserum to protein gene product 9.5 (PGP 9.5)
21. Gene expression of pituitary adenylate cyclase activating polypeptide (PACAP) in the rat hypothalamus
22. Pituitary adenylate cyclase‐activating polypeptide, vasoactive intestinal polypeptide, and helospectin in human corpus cavernosum: localization and functional effects
23. Comparison of the responses to drugs acting on adrenoceptors and muscarinic receptors in human isolated corpus cavernosum and cavernous artery
24. Functional expression and tissue distribution of a novel receptor for vasoactive intestinal polypeptide
25. Inhibitory transmission in tenia coli mediated by distinct vasoactive intestinal peptide and apamin‐sensitive pituitary adenylate cyclase activating peptide receptors
26. A simple method of reducing the fading of immunofluorescence during microscopy
27. Coexistence of nitric oxide synthase and vasoactive intestinal polypeptide in nerve terminals of human corpus cavernosum (abstract). J
28. The role of vasoactive intestinal polypeptide as a neurotransmitter in penile erection
29. Penile response to intracavernosal vasoactive intestinal polypeptide alone and in combination with other vasoactive agents
30. A novel peptide which stimulates adenylate cyclase: molecular cloning and characterization of the ovine and human cDNAs
31. Helodermin‐ and helospectin‐like immunoreactivity in the rat brain: an immunochemical and immunohistochemical study
32. Smooth muscle of the male reproductive tract. In Handbook of Experimental Pharmacology, vol. 11
33. Immunohistochemical demonstration of a novel hypothalamic peptide, pituitary adenylate cyclase‐activating polypeptide, in the ovine hypothalamus
34. Vasoactive intestinal polypeptide (VIP) in the male genitor‐urinary tract; concentration and motor effect
35. Changes in the Vipergic, cholinergic and adrenergic innervation of human penile tissue in diabetic and non‐diabetic impotent males. J
36. Protein gene product 9.5 (PGP 9.5). A new neuronal marker visualizing the whole uterine innervation and pregnancy‐induced and developmental changes in the guinea‐pig
37. Chemical coding of endocrine cells of the airways: presence of helodermin‐like peptides
38. Nonadrenergic non‐cholinergic inhibitory transmitters of the gut
39. Isolation of a novel 38 residue‐hypothalamic polypeptide which stimulates adenylate cyclase in pituitary cells
40. Isolation of a neuropeptide corresponding to the N‐terminal 27 residues of the pituitary adenylate cyclase activating polypeptide with 38 residues (PACAP38)
41. Pituitary adenylate cyclase activating peptide is a sensory neuropeptide‐Immunocytochemical and immunochemical evidence
42. Molecular cloning and expression of a cDNA encoding a receptor for pituitary adenylate cyclase activating polypeptide (PACAP)
43. Vasodilator effect of pituitary adenylate cyclase activating polypeptide (PACAP) on femoral blood flow in dogs
44. Nitric oxide synthase‐containing, peptide‐containing, and acetylcholinesterase‐positive nerves in the cat lower oesophagus
45. The nitric oxide pathway in the cat esophagus; localization of nitric oxide synthase and functional aspects
46. Amino acid sequences of helospectins, new members of the glucagon superfamily, found in Gila monster venom
47. Vipergic nerves in the penis
48. Immunoreactive helodermin‐like peptides in rat: a new class of mammalian neuropeptides related to secretin and VIP
49. A clinical trial of intracavernous vasoactive intestinal peptide to induce penile erection
50. Characterization of a common VIP‐PACAP receptor in human small intestinal epithelium
51. Content and distribution of vasoactive intestinal polypeptide (VIP) in cavernous tissues of human penis
52. Two high affinity binding sites for pituitary adenylate cyclase activating polypeptide have different distributions
53. Pituitary adenylate cyclase activating peptide: a novel vasoactive intestinal peptide‐like neuropeptide in the gut
54. Effects of intracavernous simultaneous injection of acetylcholine and vasoactive intestinal polypeptide on canine penile erection
55. Immunohistochemical localization of the neuropeptide, pituitary adenylate cyclase‐activating polypeptide (PACAP), in human and primate hypothalamus
56. Intracavernous injection of vasoactive intestinal polypeptide (VIP) does not induce erection in man per se
57. Characterization of an immunofluorescence technique for the demonstration of coexisting neuro‐transmitters within nerve fibers and terminals